Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |